Afficher la notice abrégée

dc.contributor.editorEcke, Thorsten
dc.contributor.editorOtto, Thomas
dc.date.accessioned2021-05-01T15:08:38Z
dc.date.available2021-05-01T15:08:38Z
dc.date.issued2021
dc.identifierONIX_20210501_9783039436859_131
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/68385
dc.description.abstractAfter our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.otherMetallothionein
dc.subject.otherurothelium
dc.subject.otherurothelial cancer
dc.subject.othercadmium exposure
dc.subject.otherzinc transporter
dc.subject.otherbladder
dc.subject.otherTAGLN
dc.subject.otherF-actin
dc.subject.otherPTEN
dc.subject.otherp53
dc.subject.othertumorigenesis
dc.subject.otherproliferation
dc.subject.otherinvasion
dc.subject.otherTERT promoter mutations
dc.subject.otherFGFR3
dc.subject.othernon muscle invasive bladder cancer
dc.subject.otherBCG therapy
dc.subject.otherbladder cancer
dc.subject.otherJAK-STAT pathway
dc.subject.othercombination therapy
dc.subject.otheroncolytic adenovirus
dc.subject.othervirotherapy
dc.subject.otherSTAT3/5 inhibitor
dc.subject.otherJAK inhibitor
dc.subject.otherXVir-N-31
dc.subject.otherbladder cancer detection
dc.subject.otherurinary biomarkers
dc.subject.otherDNA methylation
dc.subject.otherECRG4
dc.subject.otherITIH5
dc.subject.othern/a
dc.subject.otherbiomarker
dc.subject.othercancer
dc.subject.othergrade
dc.subject.othermetabolomics
dc.subject.otherMS
dc.subject.otherNMR
dc.subject.otherbiomarkers
dc.subject.othertumor markers
dc.subject.otherprognosis
dc.subject.otherheparanase
dc.subject.othersyndecan-1
dc.subject.otherheparan sulfate proteoglycans (HSPGs)
dc.subject.otherurothelial carcinoma
dc.subject.othermiRNA
dc.subject.otherquantitative PCR
dc.subject.othertumor marker
dc.subject.othervoided urine cytology
dc.subject.otherKDM7A
dc.subject.otherhistone demethylase
dc.subject.otherTC-E 5002
dc.subject.otherandrogen receptor
dc.subject.otherdrug resistance
dc.subject.othernon-invasive detection
dc.subject.othertelomerase
dc.subject.othersomatic mutations
dc.subject.otherTERT promoter region
dc.subject.othermuscle-invasive bladder cancer
dc.subject.otherchemotherapy
dc.subject.otherimmunotherapy
dc.subject.otherpersonalized medicine
dc.subject.otherpredictive biomarker
dc.subject.othersurvivin
dc.subject.otherBIRC5
dc.subject.othermacrophage
dc.subject.otherKRT20
dc.subject.otherERBB2
dc.subject.otherMIBC
dc.subject.otherprediction
dc.subject.otherRT-qPCR
dc.subject.otheradjuvant chemotherapy
dc.subject.othersurvival
dc.titleDiagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision 2.0
dc.typebook
oapen.identifier.doi10.3390/books978-3-03943-686-6
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783039436859
oapen.relation.isbn9783039436866
oapen.pages240
oapen.place.publicationBasel, Switzerland


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/